Pembrolizumab with platinum-based chemotherapy for untreated advanced oesophageal cancer [ID3741]

£656.3K GBP

Funder	National Institute for Health Research
Recipient Organization	University of Exeter
Country	United Kingdom
Start Date	Feb 10, 2021
End Date	Aug 03, 2021
Duration	174 days
Number of Grantees	1
Roles	Award Holder
Data Source	Europe PMC
Grant ID	`NIHR133837`

Grant Description

To appraise the clinical and cost effectiveness of pembrolizumab with platinum-based chemotherapy within its marketing authorisation for unresectable locally advanced or metastatic oesophageal cancer or gastroesophageal junction adenocarcinoma that has not been previously treated.